SRPLNSEShree Ram Proteins LimitedHighNeutral
Announced Thu, 29 May · 14:41 IST

Shree Ram Proteins Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025.

Going ConcernAdverse OpinionRevenue DeclinePat NegativeEbitda Margin CompressionExceptional ItemResults View source PDF
Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Shree Ram Proteins Limited reported deeply negative results for FY25, with total income collapsing to Rs. 255.40 lakhs from Rs. 1,510.89 lakhs in FY24, a drop of about 83%. The net loss widened sharply to Rs. 2,107.50 lakhs (FY24 loss: Rs. 958.48 lakhs), translating to EPS of Rs. (0.98) versus Rs. (0.45) earlier. A major one-time inventory write-off of Rs. 400.52 lakhs contributed to the loss. Crucially, the statutory auditor (HB Kalaria & Associates) issued an ADVERSE OPINION, stating the financials do not give a true and fair view. The auditor flagged material going-concern uncertainty due to loan defaults with Union Bank of India (failed to pay 2nd and final OTS installments totalling over Rs. 2,232 lakhs), a history of CIRP proceedings, and absence of balance confirmations, physical inventory verification, and impairment assessments. Notably, the company's filing to the exchange wrongly states the auditor gave an 'unmodified opinion', contradicting the actual report.

Likely market impact

This is a severe red flag for shareholders — the auditor's adverse opinion, going-concern doubt, and the company's misrepresentation of the audit opinion suggest serious financial distress and governance concerns. The stock is highly risky and may face regulatory scrutiny for the contradictory disclosure.